Research Topics
| R N PriceSummaryAffiliation: Menzies School of Health Research Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Towards optimal design of anti-malarial pharmacokinetic studiesJulie A Simpson
Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria, Australia
Malar J 8:189. 2009....
Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparumMuhammad Karyana
International Health Division, Menzies School of Health Research, Darwin, Australia
Malar J 7:148. 2008..Multidrug resistance has emerged to both Plasmodium vivax and Plasmodium falciparum and yet the comparative epidemiology of these infections is poorly defined...
The effect of varying analytical methods on estimates of anti-malarial clinical efficacyWendy J Verret
Nuffield Department of Clinical Medicine, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, UK
Malar J 8:77. 2009..The aim of this study was to quantify the magnitude of the differences between efficacy estimates derived from these approaches and identify the factors underlying these differences...
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivaxA R Hasugian
National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
Antimicrob Agents Chemother 53:1094-9. 2009..001). Although amodiaquine results in a rapid clinical response, the risk of recurrence by day 28 is unacceptably high, reducing its suitability as an alternative treatment of infection by chloroquine-resistant P. vivax in this region...
Vivax malaria: neglected and not benignRic N Price
International Health Program, Menzies School of Health Research and Charles Darwin University, Casuarina, Darwin, Northern Territory 0811, Australia
Am J Trop Med Hyg 77:79-87. 2007..Without these, vivax malaria will continue to be neglected by ministries of health, policy makers, researchers, and funding bodies...
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistanceRic N Price
International Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia
Curr Opin Infect Dis 22:430-5. 2009..vivax infection. We review the evidence for severe disease and the spread of drug-resistant P. vivax and speculate how these maybe related...
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malariaA R Hasugian
National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
Clin Infect Dis 44:1067-74. 2007..In southern Papua, Indonesia, where both strains of plasmodia coexist, we have been conducting a series of studies to optimize treatment strategies...
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonA Ratcliff
International Health Programme, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
Lancet 369:757-65. 2007..Our aim was to compare the safety and efficacy of dihydroartemisinin-piperaquine with that of artemether-lumefantrine in patients with uncomplicated malaria caused by multidrug-resistant P falciparum and P vivax...
Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malariaR N Price
Information Health Division, Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, Darwin, NT 0811, Australia
Antimicrob Agents Chemother 51:4090-7. 2007..Lower plasma piperaquine concentrations and higher failure rates in children suggest that dose revision may be warranted in this age group...
In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivaxR N Price
Global Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia
Antimicrob Agents Chemother 54:5146-50. 2010..vivax and P. falciparum highlights the suitability of the drug as a novel partner for artemisinin-based combination therapy in regions where the two species are coendemic...
In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, IndonesiaH Siswantoro
National Institute of Health Research and Development, Jakarta, Indonesia
Antimicrob Agents Chemother 55:197-202. 2011..8 nM). Chloroquine retains adequate efficacy against P. ovale and P. malariae, but its marked stage specificity of action may account for reports of delayed parasite clearance times...
Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivaxR Suwanarusk
International Health Division, Menzies School of Health Research, Darwin, Australia
J Infect Dis 198:1558-64. 2008..Multidrug-resistant strains of Plasmodium vivax are emerging in Southeast Asia...
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, IndonesiaA Ratcliff
International Health Program, Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia
Trans R Soc Trop Med Hyg 101:351-9. 2007..falciparum and P. vivax exists both to first- and second-line therapies. Preliminary data indicate that amodiaquine retains superior efficacy compared with CQ for CQ-resistant P. vivax...
Determinants of in vitro drug susceptibility testing of Plasmodium vivaxB Russell
International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia
Antimicrob Agents Chemother 52:1040-5. 2008..vivax and suggest that susceptibility to chloroquine may be associated with variable growth rates. These findings have important implications for the phenotypic and downstream genetic characterization of P. vivax...
Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphismsRossarin Suwanarusk
International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia
PLoS ONE 2:e1089. 2007..vivax infections has reached high levels in the eastern provinces of Indonesia, however, in vitro characterization of chloroquine resistance and its associated molecular profile have yet to be determined...
Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, IndonesiaGraeme P Maguire
International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia
J Infect Dis 192:1966-74. 2005..Persistent impairment long after clearance of parasitized RBCs suggests prolonged posttreatment inflammatory alveolar-capillary injury...
Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammationNicholas M Anstey
International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT 0811, Australia
J Infect Dis 195:589-96. 2007..The mechanisms underlying lung injury in vivax malaria are not well understood. Inflammatory responses to Plasmodium falciparum and P. vivax, to our knowledge, have not previously been compared at an organ level...
Improving case definitions for severe malariaNicholas M Anstey
International Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia
PLoS Med 4:e267. 2007
Comparison of three molecular methods for the detection and speciation of Plasmodium vivax and Plasmodium falciparumPrapaporn Boonma
Department of Parasitology, Faculty of Public Health, Mahidol University, Bangkok, Thailand
Malar J 6:124. 2007..PCR assays offer an alternative to microscopy which has been shown to have superior sensitivity and specificity. Unfortunately few comparative studies have been done on the various molecular based speciation methods...
Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemicJeanne Rini Poespoprodjo
District Health Authority, School of Health Research National Institute of Health Research and Development Malaria Research Program, Indonesia
Clin Infect Dis 46:1374-81. 2008..Plasmodium falciparum infection exerts a considerable burden on pregnant women, but less is known about the adverse consequences of Plasmodium vivax infection...
Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responsesTonia Woodberry
International Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia
J Infect Dis 198:134-42. 2008..In cross-sectional and longitudinal studies, we measured MSP5 antibody responses in Papuans with acute Plasmodium falciparum malaria, Plasmodium vivax malaria, and mixed P. falciparum and P. vivax malaria and in those with past exposure...
Safety profile of L-arginine infusion in moderately severe falciparum malariaTsin W Yeo
International Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia
PLoS ONE 3:e2347. 2008..We assessed clinical symptoms, hemodynamic status and biochemical parameters before and after a single L-arginine infusion in adults with moderately severe malaria...
Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malariaTsin W Yeo
International Health Division, Menzies School of Health Research and Charles Darwin University, Darwin NT 0810, Australia
J Exp Med 204:2693-704. 2007..Clinical trials in SM of adjunctive agents to improve endothelial NO bioavailability, including l-arginine, are warranted...
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malariaRic N Price
Centre for Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom
Clin Infect Dis 42:1570-7. 2006..Our study examined the relative contributions of host, pharmacokinetic, and parasitological factors in determining the therapeutic response to artemether-lumefantrine (AL)...
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malariaChristopher V Plowe
Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, HSF1 480, Baltimore, Maryland 21201, USA
Malar J 6:121. 2007....
Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malariaOliver T Mytton
Shoklo Malaria Research Unit, Mae Sot, Thailand
Am J Trop Med Hyg 77:447-50. 2007..At therapeutic doses, DP does not have clinically significant effects on the electrocardiogram...
Plasmodium vivax trophozoites insensitive to chloroquineWesley W Sharrock
International Health Program, Infectious Diseases Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia
Malar J 7:94. 2008..vivax clinical isolates suggest that only ring stages (early trophozoites) are sensitive to chloroquine. In this study, the stage specific action of chloroquine was investigated in synchronous cryopreserved isolates of P. vivax...
Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrationsTsin W Yeo
International Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia
J Infect Dis 198:602-8. 2008..L-Arginine infusion improves endothelial function in moderately severe malaria. Neither the longitudinal course of endothelial dysfunction nor factors associated with recovery have been characterized in severe malaria...
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, IndonesiaEmiliana Tjitra
National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
PLoS Med 5:e128. 2008..The aim of the study was to review the spectrum of disease associated with malaria due to Pv and P. falciparum (Pf) in patients presenting to a hospital in Timika, southern Papua, Indonesia...
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy numberRic N Price
Department of Cellular and Molecular Medicine-Infectious Diseases, St George's Hospital Medical School, London, UK
Lancet 364:438-47. 2004..Monitoring of pfmdr1 copy number will be useful in epidemiological surveys of drug resistance in P falciparum, and potentially for predicting treatment failure in individual patients...
